Total Panax notoginseng saponins treats diabetic kidney disease in mice by regulating the TXNIP/NLRP3 signaling pathway
Clinical Traditional Medicine and Pharmacology · 2025-12 · 6 (4) · 200245
DOI: 10.1016/j.ctmp.2025.200245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Traditional Medicine and Pharmacology, 2025-12. Verfasst von Xiang Gao und 7 weiteren Autor:innen. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangxi University.
Abstract (Originalsprache)
The escalating diabetes pandemic presents a critical worldwide healthcare burden, with diabetic kidney disease (DKD) emerging as a predominant microvascular complication that frequently progresses to renal functional impairment. Current clinical interventions lack effective therapeutics to halt DKD progression. This study examines the nephroprotective mechanisms of Total Panax Notoginseng Saponins (TPNS) against DKD using cellular and animal models. In vitro, MPC-5 podocytes were exposed to elevated glucose concentrations (30 mM HG), with TPNS co-treatment (20 μg/mL). In vivo, Type 2 DKD was modeled using C57BLKs db/db mice treated orally with TPNS (50/100 mg/kg/day) for 8 weeks. Assessments included biochemical assays, confocal microscopy, flow cytometry, and Western blotting. In vitro,TPNS effectively counteracted HG-induced oxidative stress by inhibiting the PI3K/AKT signaling cascade, promoting NRF2 translocation into the nucleus and upregulating downstream antioxidant enzymes (HO-1, NQO1). This intervention simultaneously reduced both cytoplasmic and mitochondrial ROS levels (P
Förderung
- Guangxi University
Zitieren
APA
Gao, X., Chen, L., Zhang, C., Gao, H., Yang, S., Huang, G., Liu, Q., & Lv, J. (2025). Total Panax notoginseng saponins treats diabetic kidney disease in mice by regulating the TXNIP/NLRP3 signaling pathway. Clinical Traditional Medicine and Pharmacology, 6(4), 200245. https://doi.org/10.1016/j.ctmp.2025.200245
Vancouver
Gao X, Chen L, Zhang C, Gao H, Yang S, Huang G, et al. Total Panax notoginseng saponins treats diabetic kidney disease in mice by regulating the TXNIP/NLRP3 signaling pathway. Clinical Traditional Medicine and Pharmacology. 2025;6(4):200245. doi:10.1016/j.ctmp.2025.200245
BibTeX
@article{Gao2025,
author = {Gao, Xiang and Chen, Lingyun and Zhang, Chunting and Gao, Hongwei and Yang, Shilin and Huang, Guodong and Liu, Qiuxia and Lv, Jianzhen},
title = {Total Panax notoginseng saponins treats diabetic kidney disease in mice by regulating the TXNIP/NLRP3 signaling pathway},
journal = {Clinical Traditional Medicine and Pharmacology},
year = {2025},
volume = {6},
number = {4},
pages = {200245},
doi = {10.1016/j.ctmp.2025.200245}
}
EUVIMED